Roquefort Therapeutics plc
Roquefort Therapeutics plc (ROQ) is a Biotechnology company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Roquefort Therapeutics plc in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Great Britain
- Exchange
- London Exchange
- CEO
- Stephen Paul West
- Employees
- 7
- IPO date
- 22 Mar 2021
- ISIN
- GB00BMDQ2T15
- Website
- roquefortinvest.com
Frequently asked questions
Where is Roquefort Therapeutics plc stock listed?
Roquefort Therapeutics plc (ROQ) is listed on London Exchange.